Zivo Bioscience Inc ZIVO:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/24/22 EDT
2.61quote price arrow down-0.15 (-5.43%)
Volume
1,727
52 week range
2.37 - 10.40
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.61
  • 52 Week High10.40
  • 52 Week High Date05/27/21
  • 52 Week Low2.37
  • 52 Week Low Date01/10/22

Key Stats

  • Market Cap24.59M
  • Shares Out9.42M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.20
  • YTD % Change-9.06

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.61
  • 52 Week High10.40
  • 52 Week High Date05/27/21
  • 52 Week Low2.37
  • 52 Week Low Date01/10/22
  • Market Cap24.59M
  • Shares Out9.42M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.20
  • YTD % Change-9.06

RATIOS/PROFITABILITY

  • EPS (TTM)-1.06
  • P/E (TTM)-2.46
  • Fwd P/E (NTM)-3.18
  • EBITDA (TTM)-8.996M
  • ROE (TTM)-
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-45,528.70%
  • Debt To Equity (MRQ)17.42%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Zivo Bioscience Inc

There is no recent news for this security.

Profile

MORE
Zivo Bioscience, Inc. is a research and development company. The Company is engaged in developing bioactive compounds derived from its algal culture, targeting human and animal diseases, such as poultry coccidiosis, bovine mastitis, human cholesterol, and canine osteoarthritis. Its algal biomass contains vitamin A, protein, iron, fatty acids, non-starch polysaccharides and other micronutrients. Its products include Poultry Gut Health, Bovine Mastitis, Canine Joint Health...
John Payne
Chairman of the Board, President, Chief Executive Office, Director
Keith Marchiando
Chief Financial Officer, Treasurer, Company Secretary
Address
21 E. LONG LAKE ROAD, SUITE 100
Bloomfield Hills, MI
48304
United States